COMPANY MISSION
At eGenesis, we aspire to deliver safe and effective human transplantable cells, tissue and organs utilizing the latest advancements in genome editing.
POSITION SUMMARY
eGenesis seeks a highly motivated Finance Manager to execute the day-to-day functions of our growing finance and accounting organization. This role will assist in aspects of the monthly financial close, the annual budget and quarterly re-forecast processes. This role will also manage investor reporting. As an effective collaborator in a highly visible role, the Finance Manager will work efficiently and professionally to ensure that deliverables and deadlines are achieved. This is a full-time role based in Cambridge, MA.
PRIMARY RESPONSIBILITIES
- Analyze the accuracy of financial results, determine variance drivers and write performance commentary
- Manage monthly CRO and outside services accruals; Preclinical and Clinical spend
- Produce and distribute quarterly investor reporting; manage ad hoc requests from investor pool
- Understand the drivers of operating and capital expense variances
- Partner with line of business budget owners to inform forecasting and support budget management
- Monitor relevant trends and events impacting the business and incorporate this information into the forecast
- Identify risks and opportunities to the plan
- Collaborate with all members of the company to collect necessary information to produce accurate financial reporting
- Proactively identify and recommend improved processes for increased efficiency and better controls
- Other duties as assigned
BASIC QUALIFICATIONS
- Bachelor’s degree in accounting, plus public accounting experience
- 5+ years of corporate financial planning experience; early-stage clinical biotech experience a plus
- Experience with NetSuite and Vena preferred
- Experience with management reporting, financial analysis, budgeting, forecasting
- Ensure high standards of accuracy and consistency of data, attention to detail and efficiency
- Comfort with flexible and often competing priorities in a fast-paced, dynamic, biotechnology environment
What We Do
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis has the capability to solve the global organ crisis by providing an alternative to allotransplantation.
eGenesis is uniquely positioned to reinvigorate the field of xenotransplantation by addressing both the key virology and immunology hurdles that have impeded its advancement to date and provide commercially-viable products to save and enhance the lives of patients in need.
